In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses

Invest Ophthalmol Vis Sci. 2014 Jul 15;55(8):4896-904. doi: 10.1167/iovs.14-14855.

Abstract

Purpose: The purpose of this study was to evaluate ciprofloxacin-releasing silicone hydrogel contact lens materials in vitro and in vivo for the treatment of microbial keratitis.

Methods: Model silicone hydrogel contact lens materials were manufactured using a molecular imprinting technique to modify ciprofloxacin release kinetics. Various contact lens properties, including light transmission and surface wettability, were determined, and the in vitro ciprofloxacin release kinetics elucidated using fluorescence spectrophotometry. The materials then were evaluated for their ability to inhibit Pseudomonas aeruginosa growth in vitro and in an in vivo rabbit model of microbial keratitis.

Results: Synthesized lenses had similar material properties to commercial contact lens materials. There was a decrease in light transmission in the shorter wavelengths due to incorporation of the antibiotic, but over 80% light transmission between 400 and 700 nm. Modified materials released for more than 8 hours, significantly longer than unmodified controls (P < 0.05). In vivo, there was no statistically significant difference between the number of colony-forming units (CFU) recovered from corneas treated with eye drops and those treated with one of two modified contact lenses (P > 0.05), which is significantly less than corneas treated with unmodified control lenses or those that received no treatment at all (P < 0.05).

Conclusions: These novel contact lenses designed for the extended release of ciprofloxacin may be beneficial to supplement or augment future treatments of sight-threatening microbial keratitis.

Keywords: ciprofloxacin; contact lens; drug delivery; microbial keratitis; molecular imprinting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / therapeutic use
  • Ciprofloxacin / pharmacokinetics*
  • Ciprofloxacin / therapeutic use
  • Coated Materials, Biocompatible
  • Contact Lenses, Extended-Wear*
  • Cornea / drug effects
  • Cornea / metabolism*
  • Cornea / pathology
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / therapeutic use
  • Disease Models, Animal
  • Equipment Design
  • Eye Infections, Bacterial / diagnosis
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / microbiology
  • Humans
  • Keratitis / diagnosis
  • Keratitis / drug therapy*
  • Keratitis / microbiology
  • Pseudomonas Infections / diagnosis
  • Pseudomonas Infections / microbiology
  • Pseudomonas Infections / therapy*
  • Pseudomonas aeruginosa / isolation & purification
  • Rabbits
  • Silicone Elastomers*
  • Spectrometry, Fluorescence

Substances

  • Anti-Bacterial Agents
  • Coated Materials, Biocompatible
  • Delayed-Action Preparations
  • Silicone Elastomers
  • Ciprofloxacin